$ECL

Beck Christophe sold $5.0M of ECL

Beck Christophe (CHAIRMAN, PRESIDENT & CEO) sold 17,862 shares of ECOLAB INC. (ECL) at $280.14 ($5.00M total) on 2026-08-18.

Original reporting
SEC EDGAR · Beck Christophe
Published Aug 20, 2026, 8:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ECL
Bearish
medium confidence
Mentioned
$ECL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECLBearishLow
01

Why it matters

The disclosed sale may trigger short interest and affect investor sentiment.

02

Market read

Ecolab's stock could see short-term volatility due to the insider sell.

03

What to watch

Potential tax planning or diversification motives for the CEO.

Relevance 6/10Novelty 7/10Timing: filed 2026-08-20

Background

Form 4 filings disclose insider transactions; a CEO sell is closely watched by traders.

Company-level read

Ticker impact

$ECLBearishMedium confidence
Context

CEO Beck Christophe sold 17,862 shares for $5.0M, reducing his stake to 72,932 shares.

Expected impact

Possible short-term downside pressure.

Evidence & confidence

The sale size is material for a mid-cap company and the insider is the top executive.

Market effects

Minimal impact on the broader industrial chemicals sector.

Limited to U.S. markets where ECL trades.

Low global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing, not a negative signal.

Key entities

  • Beck Christophe

    Chairman, President & CEO of Ecolab Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECLMed

Raised 2026 Guidance and 89-Year Dividend Streak Could Be A Game Changer For Ecolab (ECL)

Ecolab (ECL) raised its 2026 adjusted earnings guidance, highlighting growth in High-Tech, Digital, and Life Sciences. The company declared a $0.73 quarterly dividend, extending an 89-year streak. Management emphasized pricing, productivity, and share gains, despite rising debt and acquisition costs. Ecolab projects $20.9B revenue and $3.3B earnings by 2029, requiring 7.5% yearly revenue growth.

$ECLMed

Ecolab's CoolIT Deal Raises AI Upside but Also Debt and Cost Risks

Ecolab Inc. (ECL) acquired CoolIT Systems for $4.75 billion, expanding its AI infrastructure and data-center cooling capabilities. The deal aims to grow High-Tech sales to $4 billion by 2030 but increases debt to $13.18 billion, raising financial concerns. Ecolab's management expects higher growth and margins but warns of short-term earnings offsets due to acquisition costs.

$ECLMed

Ecolab bets $7bn to tackle AI's growing water problem

Ecolab said it has spent $7 billion in the past six months to address water use from AI data centers, citing water as a key constraint. The company’s main move was a $4.75 billion acquisition of Calgary-based CoolIT Systems, which uses closed-loop liquid cooling to capture chip heat without misting or evaporating water. Ecolab reported $16 billion in annual revenue and targets 2030 sustainability goals.

$ECLMed

Ecolab Inc. Q2 2026 Earnings Call Summary

Ecolab reported Q2 2026 earnings call updates, citing value-based pricing and energy surcharges offsetting rising commodity costs. Global High-Tech growth accelerated after the CoolIT acquisition, and Life Sciences grew 15%. Management raised the 2030 High-Tech sales target to $4B and guided H2 organic sales growth of 6% to 7% with adjusted operating margin of 19%.

$ECLMedAI 8/10

Ecolab Inc (ECL) Q2 2026 Earnings Call Transcript

Ecolab (NYSE: ECL) held its Q2 2026 earnings call. The company reported adjusted EPS up 11%, driven by 5% organic sales growth, stable organic gross margin, and productivity. It said pricing strengthened to 4% in Q2, targeting 5% to 6% in the second half, while volumes rose 1%. Ecolab also cited Life Sciences growth (15%) and Global High-Tech growth (29%) after the July 2 acquisition of Coolite Systems.